Text Size

Compliance and Administration Technique in Topical Drug Therapy of Glaucoma

This study has been completed.
Sponsor:
Information provided by:
University of Toronto
ClinicalTrials.gov Identifier:
NCT00303121
First received: March 14, 2006
Last updated: October 10, 2006
Last verified: June 2006
History of Changes
  Purpose

Clinic-based evaluation of patients compliance with topical medications in the treatment of glaucoma. Also assessing effectiveness of delivery techniques among these patients.


Condition
Glaucoma

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Prospective

Resource links provided by NLM:

MedlinePlus related topics: Glaucoma
U.S. FDA Resources

Further study details as provided by University of Toronto:

Estimated Enrollment: 120
Study Start Date: November 2005
Estimated Study Completion Date: June 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

glaucoma 18 years of age or older

Exclusion Criteria:

Recent ocular surgery

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00303121

Locations
Canada, Ontario
Toronto Western Hospital
Toronto, Ontario, Canada, M5T 2S8
Sponsors and Collaborators
University of Toronto
Investigators
Principal Investigator: Yvonne M Buys, MD University of Toronto
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00303121     History of Changes
Other Study ID Numbers: UHN REB 05-0631-AE
Study First Received: March 14, 2006
Last Updated: October 10, 2006
Health Authority: Canada: Ethics Review Committee

Keywords provided by University of Toronto:
Glaucoma
Compliance
Therapy
Administration technique

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on May 16, 2013